CNC Logo

Centene Corporation (CNC) 

NYSE
Market Cap
$30.71B
Sector
Healthcare
Industry
Medical—Healthcare Plans
Rank in Sector
92 of 958
Rank in Industry
3 of 11

Largest Insider Buys in Sector

CNC Stock Price History Chart

CNC Stock Performance

About Centene Corporation

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and …

Insider Activity of Centene Corporation

Over the last 12 months, insiders at Centene Corporation have bought $3.27M and sold $2.36M worth of Centene Corporation stock.

On average, over the past 5 years, insiders at Centene Corporation have bought $2.1M and sold $34.18M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Greco Thomas (director) — $3.05M. COUGHLIN CHRISTOPHER J (director) — $1.78M. Asher Andrew Lynn (Chief Financial Officer) — $1M.

The last purchase of 17,000 shares for transaction amount of $1.02M was made by Greco Thomas (director) on 2024‑12‑18.

List of Insider Buy and Sell Transactions, Centene Corporation

2024-12-18Purchasedirector
17,000
0.0034%
$59.75$1.02M+0.50%
2024-12-16Purchasedirector
10,000
0.002%
$59.44$594,400+0.69%
2024-12-16Purchasedirector
1,693
0.0003%
$59.01$99,904+0.69%
2024-12-16Purchasedirector
250
<0.0001%
$59.48$14,870+0.69%
2024-12-13Purchasedirector
5,000
0.001%
$58.86$294,300-0.08%
2024-11-13PurchaseChief Financial Officer
17,200
0.0034%
$58.14$1M+2.37%
2024-11-08PurchaseChief Executive Officer
4,117
0.0008%
$60.80$250,314-1.23%
2024-05-14Saledirector
878
0.0002%
$76.75$67,382-8.77%
2024-05-13SalePresident
8,000
0.0015%
$77.62$620,960-8.87%
2024-02-13Saledirector
10,000
0.0019%
$77.41$774,100-4.76%
2024-02-07SalePresident
12,000
0.0023%
$75.07$900,818-2.32%
2023-04-27Saledirector
1,400
0.0002%
$66.59$93,226+3.52%
2023-03-17PurchaseChief Executive Officer
30,000
0.0055%
$62.60$1.88M+10.20%
2023-02-10PurchaseEVP, CFO
3,800
0.0007%
$71.97$273,486-5.84%
2023-02-09PurchaseEVP, CFO
3,000
0.0005%
$71.89$215,670-4.28%
2023-02-08PurchaseEVP, Chief Operating Officer
6,750
0.0012%
$73.30$494,775-6.07%
2023-02-08Purchasedirector
7,000
0.0013%
$71.88$503,160-6.07%
2022-07-29SaleEVP, Chief Admin. Officer
9,000
0.0016%
$92.21$829,890-20.08%
2022-07-28Sale
1,200
0.0002%
$92.77$111,324-19.53%
2022-07-08Sale
4,480
0.0008%
$88.00$394,240-13.83%

Insider Historical Profitability

10.22%
LONDON SARAHChief Executive Officer
667229
0.1322%
$60.8320+10.2%
Asher Andrew LynnChief Financial Officer
486847
0.0964%
$60.8330<0.0001%
COUGHLIN CHRISTOPHER Jdirector
36358
0.0072%
$60.8321+0.95%
Samuels Theodore R. IIdirector
23000
0.0046%
$60.8330<0.0001%
Greco Thomasdirector
19309
0.0038%
$60.8310

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$4.78B11.4260.94M-0.41%-$19.81M0.09
BlackRock$3.32B7.9242.29M+3.59%+$115.03M0.07
Fidelity Investments$3.14B7.4939.97M+5.59%+$166.09M0.21
Capital World Investors$2.11B5.0526.95M-7.56%-$173.01M0.35
State Street$1.84B4.3923.44M+1.29%+$23.49M0.08
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.